Ayda Saldivar

1.4k citations

27 papers · 700 indexed · h-index 14

Co-authors: Dale J. Kempf Norman E. Wideburg Sudthida Vasavanonda Hing L. Sham Daniel W. Norbeck Kennan C. Marsh Chen Zhao David A. Betebenner
Topics: HIV/AIDS drug development and treatment (21 papers)Click Chemistry and Applications (13 papers)HIV Research and Treatment (13 papers)
Cited by: Virology Infectious Diseases Organic Chemistry
Journals: Biochemistry Biochemical and Biophysical Research Communications FEBS Letters
Partner nations: United States United Kingdom Australia

In The Last Decade

Ayda Saldivar

27 papers receiving 666 citations

Peers

Countries citing papers authored by Ayda Saldivar

Since Specialization

Citations

This map shows the geographic impact of Ayda Saldivar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayda Saldivar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayda Saldivar more than expected).

Fields of papers citing papers by Ayda Saldivar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayda Saldivar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayda Saldivar. The network helps show where Ayda Saldivar may publish in the future.

Co-authorship network of co-authors of Ayda Saldivar

This figure shows the co-authorship network connecting the top 25 collaborators of Ayda Saldivar. A scholar is included among the top collaborators of Ayda Saldivar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayda Saldivar. Ayda Saldivar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strains 2005 ·Bioorganic & Medicinal Chemistry Letters ·Chen Zhao,Hing L. Sham,Minghua Sun,Vincent S. Stoll,Kent D. Stewart,Shuqun Lin,Hongmei Mo,Sudthida Vasavanonda,Ayda Saldivar,Chang Park,Edith McDonald,Kennan C. Marsh,Larry L. Klein,Dale J. Kempf,Daniel W. Norbeck	17
2	Novel lopinavir analogues incorporating heterocyclic replacements of six-member cyclic urea––synthesis and structure–activity relationships 2004 ·Bioorganic & Medicinal Chemistry Letters ·Hing L. Sham,David A. Betebenner,William Rosenbrook,Thomas Herrin,Ayda Saldivar,Sudthida Vasavanonda,Jacob J. Plattner,Daniel W. Norbeck	15
3	Synthesis and SAR studies of potent HIV protease inhibitors containing novel dimethylphenoxyl acetates as P2 ligands 2003 ·Bioorganic & Medicinal Chemistry Letters ·Xiaoqi Chen,Dale J. Kempf,(unknown),Hing L. Sham,Sudthida Vasavanonda,Norman E. Wideburg,Ayda Saldivar,Kennan C. Marsh,Edith McDonald,Daniel W. Norbeck	17
4	Hepatitis C NS3 protease inhibition by peptidyl-α-ketoamide inhibitors: kinetic mechanism and structure 2003 ·Archives of Biochemistry and Biophysics ·Yaya Liu,Vincent S. Stoll,Paul L. Richardson,Ayda Saldivar,Jeffrey L. Klaus,Akhteruzzaman Molla,William E. Kohlbrenner,Warren M. Kati	16
5	Influenza Neuraminidase Inhibitors: Structure-Based Design of a Novel Inhibitor Series 2003 ·Biochemistry ·Vincent S. Stoll,Kent D. Stewart,Clarence J. Maring,Steven W. Muchmore,Vincent L. Giranda,(unknown),Gary Wang,Yuanwei Chen,(unknown),Chen Zhao,(unknown),Darold L. Madigan,Yibo Xu,Ayda Saldivar,Warren M. Kati,Graeme Laver,Thomas J. Sowin,Hing L. Sham,Jonathan Greer,Dale J. Kempf	98
6	Synthesis and structure–activity relationships of a novel series of HIV-1 protease inhibitors encompassing ABT-378 (Lopinavir) 2002 ·Bioorganic & Medicinal Chemistry Letters ·Hing L. Sham,David A. Betebenner,Xiaoqi Chen,Ayda Saldivar,Sudthida Vasavanonda,Dale J. Kempf,Jacob J. Plattner,Daniel W. Norbeck	14
7	Novel lopinavir analogues incorporating non-Aromatic P-1 side chains—Synthesis and structure–Activity relationships 2002 ·Bioorganic & Medicinal Chemistry Letters ·Hing L. Sham,Chen Zhao,Leping Li,David A. Betebenner,Ayda Saldivar,Sudthida Vasavanonda,Dale J. Kempf,Jacob J. Plattner,Daniel W. Norbeck	41
8	Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir) 2001 ·Bioorganic & Medicinal Chemistry Letters ·Hing L. Sham,David A. Betebenner,Thomas Herrin,Gondi Kumar,Ayda Saldivar,Sudthida Vasavanonda,Akhter Molla,Dale J. Kempf,Jacob J. Plattner,Daniel W. Norbeck	15
9	Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands 1998 ·Bioorganic & Medicinal Chemistry Letters ·Xiaoqi Chen,Dale J. Kempf,Hing L. Sham,(unknown),(unknown),Marina Korneyeva,Sudthida Vasavanonda,Norman E. Wideburg,Ayda Saldivar,Kennan C. Marsh,Edith McDonald,Daniel W. Norbeck	7
10	Lack of stereospecificity in the binding of the P2 amino acid of ritonavir to HIV protease 1997 ·Bioorganic & Medicinal Chemistry Letters ·Dale J. Kempf,Akhteruzzaman Molla,Kennan C. Marsh,Chulyong Park,A. David Rodrigues,Marina Korneyeva,Sudthida Vasavanonda,Edith McDonald,Charles A. Flentge,Steven W. Muchmore,Norman E. Wideburg,Ayda Saldivar,(unknown),Warren M. Kati,Kent D. Stewart,Daniel W. Norbeck	4
11	Novel Azacyclic Ureas That Are Potent Inhibitors of HIV-1 Protease 1996 ·Biochemical and Biophysical Research Communications ·Hing L. Sham,Chen Zhao,Kennan C. Marsh,David A. Betebenner,Shuqun Lin,William Rosenbrook,Thomas Herrin,Leping Li,Darold L. Madigan,(unknown),Akhter Molla,Ayda Saldivar,Edith McDonald,Norman E. Wideburg,Dale J. Kempf,Daniel W. Norbeck,Jacob J. Plattner	6
12	Potent Inhibitors of the HIV-1 Protease with Good Oral Bioavailabilities 1995 ·Biochemical and Biophysical Research Communications ·Hing L. Sham,Chen Zhao,Kennan C. Marsh,David A. Betebenner,Shao‐Yu Lin,Edith McDonald,Sudthida Vasavanonda,Norman E. Wideburg,Ayda Saldivar,T. Robins,Dale J. Kempf,J. J. PLATTNER,Daniel W. Norbeck	6
13	Symmetry-Based Inhibitors of HIV Protease with Rigid P2 Amino Acid Mimics 1994 ·Protein and Peptide Letters ·Dale J. Kempf,Kent D. Stewart,(unknown),Charles A. Flentge,Norman E. Wideburg,Ayda Saldivar,Sudthida Vasavanonda,Daniel W. Norbeck	2
14	Design of orally bioavailable, symmetry-based inhibitors of HIV protease 1994 ·Bioorganic & Medicinal Chemistry ·Dale J. Kempf,Kennan C. Marsh,(unknown),(unknown),(unknown),Hing L. Sham,Chen Zhao,Sudthida Vasavanonda,William E. Kohlbrenner,Norman E. Wideburg,Ayda Saldivar,(unknown),Thomas Herrin,Daniel W. Norbeck	40
15	Pseudo‐symmetrical difluoroketones 1993 ·FEBS Letters ·Hing L. Sham,David A. Betebenner,Norman E. Wideburg,Ayda Saldivar,William E. Kohlbrenner,(unknown),Sudthida Vasavanonda,Dale J. Kempf,Jacob J. Clement,John E. Erickson,Jacob J. Plattner,Daniel W. Norbeck	12
16	Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diol 1993 ·Journal of Medicinal Chemistry ·Dale J. Kempf,(unknown),(unknown),W E Kohlbrenner,Norman E. Wideburg,Ayda Saldivar,Sudthida Vasavanonda,Kennan C. Marsh,(unknown)	107
17	Facile synthesis of potent HIV-1 protease inhibitors containing a novel pseudo-symmetric dipeptide isostere 1993 ·Journal of the Chemical Society Chemical Communications ·Hing L. Sham,David A. Betebenner,Chen Zhao,Norman E. Wideburg,Ayda Saldivar,Dale J. Kempf,Jacob J. Plattner,Daniel W. Norbeck	13
18	Induction of calf thymus topoisomerase II-mediated DNA breakage by the antibacterial isothiazoloquinolones A-65281 and A-65282 1992 ·Antimicrobial Agents and Chemotherapy ·W E Kohlbrenner,Norman E. Wideburg,(unknown),Ayda Saldivar,D. T. W. CHU	51
19	Potent HIV-1 protease inhibitors with antiviral activities in vitro 1991 ·Biochemical and Biophysical Research Communications ·Hing L. Sham,David A. Betebenner,Norman E. Wideburg,Ayda Saldivar,William E. Kohlbrenner,Sudthida Vasavanonda,Dale J. Kempf,Daniel W. Norbeck,Chen Zhao,Jacob J. Clement,John E. Erickson,Jacob J. Plattner	17
20	Participation of the GABA-benzodiazepine system in the inhibition of defensive burying produced by ejaculation 1990 ·Behavioural Pharmacology ·Alonso Fernández‐Guasti,Ayda Saldivar	15

About Ayda Saldivar

Ayda Saldivar is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 27 papers that have together received 700 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (21 papers), Click Chemistry and Applications (13 papers) and HIV Research and Treatment (13 papers). The work is most often cited by research in Virology (170 citations), Infectious Diseases (272 citations) and Organic Chemistry (314 citations). Ayda Saldivar has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Dale J. Kempf, Norman E. Wideburg, Sudthida Vasavanonda, Hing L. Sham, Daniel W. Norbeck, Kennan C. Marsh, Chen Zhao, David A. Betebenner, Jacob J. Plattner and W E Kohlbrenner. Their work appears in journals such as Biochemistry, Biochemical and Biophysical Research Communications and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact